Global WholeHealth Partners Corp.
Global WholeHealth Partners Email Alerts: Click to Subscribe
View Company Website: Click to View
Report Link: Updated Research Report (Dated 12/1/2020)
Analyst: Howard Halpern
Taglich Rating: Speculative Buy
Price Target: NA
Time Horizon: NA
Rating Established: October 15, 2020
Price When Established: $1.11
Most Recent Report: December 1, 2020
Price When Issued: $1.48
New information will be posted soon...
Global WholeHealth Partners Corp., headquartered in San Clemente, CA, was founded to develop, manufacture and market in-vitro and rapid diagnostic tests. The company’s vision is to provide infectious disease diagnostics and molecular solutions that reduce the time to diagnose medical results. The company plans to produce and sell rapid diagnostic tests that include but is not limited to, Corona Viruses including COVID-19, Ebola, ZIKA, Dengue, Malaria, Influenza, and Tuberculosis.
Please view our current disclosure and disclaimer on our most recent research report.